A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Clinical trial NCT06541704 · RECRUITING

Trial details

NCT number: NCT06541704
Sponsor: Regeneron Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Age-related Macular Degeneration (AMD)Geographic Atrophy (GA)

Start date: 2024-10-30
Primary completion: 2028-07-31
Enrollment: 975

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.